Neonatal hypoxic-ischemic encephalopathy (NHIE) in foals lacks a diagnostic test before death, leading researchers to investigate potential biomarkers.
The study focused on two biomarkers, UCHL1 and phosphorylated neurofilament H (pNF-H), measuring their plasma concentrations in 33 diagnosed foals compared to 17 healthy foals.
UCHL1 showed strong diagnostic performance with an AUC of 0.86 and higher concentrations in NHIE foals, suggesting it could be a reliable marker for brain injury in this condition.